Saudi Arabia Warned About the Tayyibat Diet. Here Is Why
A health ministry does not issue a public warning about an eating plan for the sake of it. This one followed reports of people reaching intensive care after stopping insulin.
Jun 13, 2026

Search
60 stories for“diet”
A health ministry does not issue a public warning about an eating plan for the sake of it. This one followed reports of people reaching intensive care after stopping insulin.
Jun 13, 2026

Telling people to eat differently is one thing. Telling type 1 diabetics they can stop injecting is another, and it is the claim that brought regulators down on nizam al-tayyibat.
May 25, 2026

Doctors and followers spent a year disagreeing about nizam al-tayyibat without ever contradicting each other, because they were not answering the same question.
Jul 24, 2026

Coeliac blood tests look for antibodies your body only makes while you are eating gluten. Cut it out first and the result can come back clear while the disease carries on.
Jul 16, 2026

He trained in intensive care, built an audience of millions, was struck off by his own syndicate, and died in a Dubai hotel room at 47. The arguments about him did not stop there.
May 10, 2026

DiRECT reported 46 per cent remission at one year and 36 per cent at two. Among those who lost more than ten kilograms, three quarters were in remission. At five years, the picture is more sobering and more useful.
Aug 12, 2026

Mail-in stool tests promise personalized nutrition insight, but the same sample sent to different labs can come back with conflicting advice.
Oct 3, 2025

Type 1 and type 2 are the two everyone knows. LADA is regularly mistaken for type 2 in adults, and MODY is a single-gene condition that can sometimes be treated with a tablet instead of insulin. The label decides the therapy.
Jul 7, 2026

Trials now show insufficient sleep impairs insulin sensitivity directly, independent of weight gain, reshaping how doctors talk about diabetes risk.
Nov 2, 2024

FDA approval of the first oral PCSK9 inhibitor adds a once-daily option for adults who need greater LDL reduction, but it does not replace individualized cardiovascular care.
Aug 1, 2026

Shortages pushed patients toward compounded semaglutide. The FDA's latest alert shows why that workaround carries real risk.
Aug 5, 2024

Research use only is a legal phrase, not a quality standard. Testing of peptides bought online keeps finding the wrong dose, the wrong compound, or contamination in something people inject at home.
Aug 12, 2026

One patient cannot bear a bedsheet touching their feet. Another cannot feel a nail through their shoe. Both have diabetic neuropathy, and the second is in more danger than the first.
Jul 28, 2026
